Search results
Results from the WOW.Com Content Network
The Food and Drug Administration announced Thursday that it has reversed its ban on Juul e-cigarettes while it reviews new court decisions and considers updated information provided by the vape maker.
WASHINGTON (Reuters) -The U.S. Supreme Court began hearing arguments on Monday in the U.S. Food and Drug Administration's defense of the agency's refusal to let two e-cigarette companies sell ...
The FDA has authorized the sale of only 27 e-cigarette products, and all except one have been tobacco flavored, which is not widely used by young people. It has denied millions of others.
Though the city-wide smoking ban remains intact, the vaping ban itself was lifted in 2016 due to a state law which was passed then, prohibiting e-cigarettes and vape products from being regulated in the same way as tobacco. In 2019 the city-wide vaping ban was reinstated, via a separate ordinance, by a unanimous vote from the City Council. [19 ...
The Supreme Court on Monday heard arguments about the federal regulation of flavored e-cigarettes, in a case pitting the Food and Drug Administration (FDA) against two vaping companies. Justices ...
Because of the potential relationship with tobacco laws and medical drug policies, e-cigarette legislation is being debated in many countries. [4] The companies that make e-cigarettes have been pushing for laws that support their interests. [5] In 2016 the US Department of Transportation banned the use of e-cigarettes on commercial flights. [6]
The Family Smoking Prevention and Tobacco Control Act (also known as the FSPTC Act) was signed into law by President Barack Obama on June 22, 2009. This bill changed the scope of tobacco policy in the United States by giving the FDA the ability to regulate tobacco products, similar to how it has regulated food and pharmaceuticals since the passing of the Pure Food and Drug Act in 1906.
Denny Henigan, vice president of legal and regulatory affairs for the Campaign for Tobacco-Free Kids, told CNN that any change by the Trump administration would face legal scrutiny and that FDA ...